@inbook{8bd5ff0419ed42469165cd4b2366fbc6,
title = "Gene Therapy",
abstract = "High-grade gliomas (HGG) represent the most common primary malignant tumor of the adult central nervous system. Unfortunately, the median survival after surgical intervention alone is only 6 mo and the addition of radiotherapy can extend this time to 9 mo (1,2). Consequently, efforts aimed at developing new therapies have focused on new treatment strategies that specifically target tumor cells and spare normal cells. One such modality, gene therapy, has shown promise in the spectrum of agents utilized against brain tumors. In this chapter, we review the principles of gene therapy and discuss results of recent clinical trials in which gene therapy was employed against HGG.",
keywords = "adenovirus, Gene therapy, glioma, herpes virus, immunotherapy",
author = "Lesniak, \{Maciej S.\} and Alessandro Olivi",
note = "Publisher Copyright: {\textcopyright} Humana Press Inc., Totowa, NJ 2007.",
year = "2007",
doi = "10.1007/978-1-59745-185-7\_25",
language = "English (US)",
series = "Current Clinical Oncology",
publisher = "Springer International Publishing",
pages = "419--430",
booktitle = "Current Clinical Oncology",
}